Compare IDEXX Laboratories, Inc. (IDXX) vs NetEase Inc (NTES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs NetEase Inc — how do they compare? IDEXX Laboratories, Inc. trades at $554.89 (market cap $44.48B), while NetEase Inc trades at $129.96 (market cap $86.14B). The key difference: NetEase Inc is the larger of the two by market cap, and NetEase Inc pays a 2.25% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | NTES | |
|---|---|---|
Market Cap | $44.48B | $86.14B |
Sector | Health | Media |
52-Week High | $766.68 | $159.34 |
52-Week Low | $520.87 | $109.26 |
Enterprise Value | $45.38B | $62.61B |
Dividend Yield | — | 2.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
NetEase (NTES) trades at $134.20, up 2.22% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $2.53, and maintains robust profitability with a net income margin near 30%. Recent news highlights international expansion and positive analyst sentiment, with a dividend of $0.72 paid in June 2026.
Outlook remains positive driven by earnings growth and international gaming titles, but risks include China market volatility and competitive pressures. Wall Street consensus is strongly bullish with 82% buy ratings, suggesting potential upside from current levels amid solid cash flow generation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →
